CNCMT：a Multi-center, Prospective, Single-arm Study

NCT06714084 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Cervical Cancer
PD1
CTLA4

Interventions

DRUG: Neoadjuvant Chemotherapy (NACT)
DRUG: maintenance therapy

Sponsor

Hubei Cancer Hospital

Collaborators

[object Object]
[object Object]